- Home
- EXAS vs SOLV Comparison
EXAS vs SOLV Comparison
Compare EXAS & SOLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXAS
- SOLV
- Stock Information
- Founded
- EXAS 1995
- SOLV 2023
- Country
- EXAS United States
- SOLV United States
- Employees
- EXAS N/A
- SOLV N/A
- Industry
- EXAS Medical Specialities
- SOLV
- Sector
- EXAS Health Care
- SOLV
- Exchange
- EXAS Nasdaq
- SOLV NYSE
- Market Cap
- EXAS 10.5B
- SOLV 11.5B
- IPO Year
- EXAS N/A
- SOLV N/A
- Fundamental
- Price
- EXAS $51.74
- SOLV $73.48
- Analyst Decision
- EXAS Strong Buy
- SOLV Hold
- Analyst Count
- EXAS 16
- SOLV 10
- Target Price
- EXAS $72.80
- SOLV $68.29
- AVG Volume (30 Days)
- EXAS 2.2M
- SOLV 946.4K
- Earning Date
- EXAS 02-19-2025
- SOLV 01-28-2025
- Dividend Yield
- EXAS N/A
- SOLV N/A
- EPS Growth
- EXAS N/A
- SOLV N/A
- EPS
- EXAS N/A
- SOLV 4.16
- Revenue
- EXAS $2,692,328,000.00
- SOLV $8,215,000,000.00
- Revenue This Year
- EXAS $11.81
- SOLV $2.44
- Revenue Next Year
- EXAS $11.52
- SOLV $0.38
- P/E Ratio
- EXAS N/A
- SOLV $17.66
- Revenue Growth
- EXAS 11.91
- SOLV 0.60
- 52 Week Low
- EXAS $40.62
- SOLV $47.16
- 52 Week High
- EXAS $79.62
- SOLV $77.17
- Technical
- Relative Strength Index (RSI)
- EXAS 35.28
- SOLV N/A
- Support Level
- EXAS $49.79
- SOLV N/A
- Resistance Level
- EXAS $60.88
- SOLV N/A
- Average True Range (ATR)
- EXAS 2.67
- SOLV 0.00
- MACD
- EXAS -0.59
- SOLV 0.00
- Stochastic Oscillator
- EXAS 17.58
- SOLV 0.00
About EXAS Exact Sciences Corporation
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test, a noninvasive stool-based DNA test, is a precancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.
About SOLV SOLVENTUM CORP
Solventum Corp is an independent healthcare company with a primary focus on addressing healthcare challenges. Its diverse product portfolio spans the healthcare industry, including medical solutions, oral care, health information systems, and separation and purification sciences.